Dr Heidi Staudacher
Dr

Heidi Staudacher

Email: 

Availability

Dr Heidi Staudacher is:
Available for supervision

Search Professor Heidi Staudacher’s works on UQ eSpace

93 works between 2001 and 2024
All (93) Journal Article (73) Book Chapter (3) Conference Publication (17)

61 - 80 of 93 works

2018

Journal Article

The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice

Whelan, K., Martin, L. D., Staudacher, H. M. and Lomer, M. C. E. (2018). The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. Journal of Human Nutrition and Dietetics, 31 (2), 239-255. doi: 10.1111/jhn.12530

The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice

2018

Journal Article

Long term impact of the low FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability and healthcare utilisation in irritable bowel syndrome

O'Keeffe, M., Jansen, C., Martin, L., Williams, M., Seamark, L., Staudacher, H. M., Irving, P. M., Whelan, K. and Lomer, M. C. (2018). Long term impact of the low FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability and healthcare utilisation in irritable bowel syndrome. Neurogastroenterology and Motility, 30 (1) e13154, e13154. doi: 10.1111/nmo.13154

Long term impact of the low FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability and healthcare utilisation in irritable bowel syndrome

2017

Journal Article

The challenges of control groups, placebos and blinding in clinical trials of dietary interventions

Staudacher, Heidi M, Irving, Peter M, Lomer, Miranda C E and Whelans, Kevin (2017). The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. The Proceedings of the Nutrition Society, 76 (4), 628-628. doi: 10.1017/S0029665117002816

The challenges of control groups, placebos and blinding in clinical trials of dietary interventions

2017

Journal Article

Volatile organic compounds as predictors of response to dietary intervention in irritable bowel syndrome

Rossi, Megan, Aggio, Raphael, Staudacher, Heidi M., Lomer, Miranda C., Lindsay, James O., Irving, Peter, Probert, Chris and Whelan, Kevin (2017). Volatile organic compounds as predictors of response to dietary intervention in irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 16 (3), 385-391. doi: 10.1016/j.cgh.2017.09.055

Volatile organic compounds as predictors of response to dietary intervention in irritable bowel syndrome

2017

Journal Article

A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores bifidobacterium species: a randomized controlled trial

Staudacher, Heidi Maria, Lomer, Miranda C. E., Farquharson, Freda M., Louis, Petra, Fava, Francesca, Franciosi, Elena, Scholz, Matthias, Tuohy, Kieran M., Lindsay, James O., Irving, Peter M. and Whelan, Kevin (2017). A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores bifidobacterium species: a randomized controlled trial. Gastroenterology, 153 (4), 936-947. doi: 10.1053/j.gastro.2017.06.010

A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores bifidobacterium species: a randomized controlled trial

2017

Journal Article

The low FODMAP diet: recent advances in understandings its mechanisms and efficacy in IBS

Staudacher, Heidi M. and Whelan, Kevin (2017). The low FODMAP diet: recent advances in understandings its mechanisms and efficacy in IBS. Gut, 66 (8), 1517-1527. doi: 10.1136/gutjnl-2017-313750

The low FODMAP diet: recent advances in understandings its mechanisms and efficacy in IBS

2017

Conference Publication

The challenges of control groups, placebos and blinding in clinical trials of dietary interventions

Staudacher, Heidi M., Irving, Peter M., Lomer, Miranda C. E. and Whelan, Kevin (2017). The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. Nutrition-Society Summer Meeting / Conference on New Technology in Nutrition Research and Practice, Dublin Ireland, Jul 11-14, 2016. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/S0029665117000350

The challenges of control groups, placebos and blinding in clinical trials of dietary interventions

2017

Journal Article

Editorial: metabolic adaptation of colonic microbiota to galactooligosaccharides - good news for prebiotics in irritable bowel syndrome?

Staudacher, H. M. and Cox, S. R. (2017). Editorial: metabolic adaptation of colonic microbiota to galactooligosaccharides - good news for prebiotics in irritable bowel syndrome?. Alimentary Pharmacology and Therapeutics, 45 (7), 1005-1006. doi: 10.1111/apt.13976

Editorial: metabolic adaptation of colonic microbiota to galactooligosaccharides - good news for prebiotics in irritable bowel syndrome?

2017

Journal Article

Nutritional, microbiological and psychosocial implications of the low FODMAP diet

Staudacher, Heidi Maria (2017). Nutritional, microbiological and psychosocial implications of the low FODMAP diet. Journal Gastroenterology and Hepatology, 32 (S1), 16-19. doi: 10.1111/jgh.13688

Nutritional, microbiological and psychosocial implications of the low FODMAP diet

2017

Conference Publication

Clinical Response to the Low Fodmap Diet At 12 Months: a Prospective Evaluation of Patients with Irritable Bowel Syndrome

Staudacher, Heidi, Lomer, Miranda, Lindsay, James O., Irving, Peter M., Martin, Lee, Rossi, Megan and Whelan, Kevin (2017). Clinical Response to the Low Fodmap Diet At 12 Months: a Prospective Evaluation of Patients with Irritable Bowel Syndrome. Digestive Disease Week (DDW), Chicago Il, May 06-09, 2017. W B SAUNDERS CO-ELSEVIER INC. doi: 10.1016/S0016-5085(17)33135-9

Clinical Response to the Low Fodmap Diet At 12 Months: a Prospective Evaluation of Patients with Irritable Bowel Syndrome

2017

Conference Publication

Volatile Organic Compounds Predict Response to Both Low Fodmap Diet and Probiotics in Irritable Bowel Syndrome: a Randomised Controlled Trial

Rossi, Megan, Aggio, Raphael, Staudacher, Heidi, Lomer, Miranda, Lindsay, James O., Irving, Peter M., Probert, Chris and Whelan, Kevin (2017). Volatile Organic Compounds Predict Response to Both Low Fodmap Diet and Probiotics in Irritable Bowel Syndrome: a Randomised Controlled Trial. Digestive Disease Week (DDW), Chicago Il, May 06-09, 2017. W B SAUNDERS CO-ELSEVIER INC. doi: 10.1016/S0016-5085(17)32486-1

Volatile Organic Compounds Predict Response to Both Low Fodmap Diet and Probiotics in Irritable Bowel Syndrome: a Randomised Controlled Trial

2016

Conference Publication

Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet

Staudacher, Heidi M. and Whelan, Kevin (2016). Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Summer Meeting of the Nutrition-Society / Conference on Future of Animal Products in the Human Diet: Health and Environmental Concerns, Nottingham, England, 6 - 9 July 2015. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/S0029665116000021

Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet

2016

Conference Publication

The Low FODMAP Diet Reduces Symptoms in Irritable Bowel Syndrome Compared With Placebo Diet and the Microbiota Alterations May Be Prevented by Probiotic Co-Administration: A 2x2 Factorial Randomized Controlled Trial

Staudacher, Heidi M., Lomer, Miranda, Louis, Petra, Farquharson, Freda, Lindsay, James O., Irving, Peter M. and Whelan, Kevin (2016). The Low FODMAP Diet Reduces Symptoms in Irritable Bowel Syndrome Compared With Placebo Diet and the Microbiota Alterations May Be Prevented by Probiotic Co-Administration: A 2x2 Factorial Randomized Controlled Trial. Digestive Disease Week (DDW), San Diego Ca, May 20-24, 2016. W B SAUNDERS CO-ELSEVIER INC. doi: 10.1016/S0016-5085(16)30842-3

The Low FODMAP Diet Reduces Symptoms in Irritable Bowel Syndrome Compared With Placebo Diet and the Microbiota Alterations May Be Prevented by Probiotic Co-Administration: A 2x2 Factorial Randomized Controlled Trial

2015

Journal Article

Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

Whigham, L., Joyce, T., Harper, G., Irving, P. M., Staudacher, H. M., Whelan, K. and Lomer, M. C. E. (2015). Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. Journal of Human Nutrition and Dietetics, 28 (6), 687-696. doi: 10.1111/jhn.12318

Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

2015

Journal Article

How healthy is a gluten-free diet?

Staudacher, Heidi M. and Gibson, Peter R. (2015). How healthy is a gluten-free diet?. British Journal of Nutrition, 114 (10), 1539-1541. doi: 10.1017/S000711451500330X

How healthy is a gluten-free diet?

2015

Journal Article

Probiotics for lactose intolerance and irritable bowel syndrome

Staudacher, Heidi (2015). Probiotics for lactose intolerance and irritable bowel syndrome. British journal of community nursing, 20 (S1), S13-S14. doi: 10.12968/bjcn.2015.20.Sup6a.S12

Probiotics for lactose intolerance and irritable bowel syndrome

2015

Conference Publication

Long term effectiveness of short chain fermentable carbohydrate (Fodmap) restriction in patients with irritable bowel syndrome

Martin, L., van Vuuren, C., Seamark, L., Williams, M., Staudacher, H., Irving, P. M., Whelan, K. and Lomer, M. C. (2015). Long term effectiveness of short chain fermentable carbohydrate (Fodmap) restriction in patients with irritable bowel syndrome. 2nd Digestive Disorders Federation Conference, London, England, United Kingdom, Jun 22-25, 2015. London, United Kingdom: B M J Group. doi: 10.1136/gutjnl-2015-309861.104

Long term effectiveness of short chain fermentable carbohydrate (Fodmap) restriction in patients with irritable bowel syndrome

2015

Conference Publication

Advice from a dietitian regarding the low Fodmap diet broadly maintains nutrient intake and does not alter fibre intake

Staudacher, H., Ross, F. S., Briscoe, Z. M., Irving, P. M., Whelan, K. and Lomer, M. C. (2015). Advice from a dietitian regarding the low Fodmap diet broadly maintains nutrient intake and does not alter fibre intake. 2nd Digestive Disorders Federation Conference, London, England, United Kingdom, Jun 22-25, 2015. London, United Kingdom: B M J Group. doi: 10.1136/gutjnl-2015-309861.298

Advice from a dietitian regarding the low Fodmap diet broadly maintains nutrient intake and does not alter fibre intake

2015

Conference Publication

The impact of low FODMAP dietary advice and probiotics on symptoms in irritable bowel syndrome: A randomised, placebo-controled, 2 x 2 factorial trial

Staudacher, H., Lomer, M. C., Lindsay, J. O., Irving, P. M. and Whelan, K. (2015). The impact of low FODMAP dietary advice and probiotics on symptoms in irritable bowel syndrome: A randomised, placebo-controled, 2 x 2 factorial trial. 2nd Digestive Disorders Federation Conference, London, England, United Kingdom, Jun 22-25, 2015. London, United Kingdom: B M J Group. doi: 10.1136/gutjnl-2015-309861.103

The impact of low FODMAP dietary advice and probiotics on symptoms in irritable bowel syndrome: A randomised, placebo-controled, 2 x 2 factorial trial

2014

Conference Publication

Symptom Response Following Advice On a Diet Low in Short-Chain Fermentable Carbohydrates (Fodmaps) for Functional Bowel Symptoms in Patients with Ibd

Joyce, T., Staudacher, H., Whelan, K., Irving, P. and Lomer, M. (2014). Symptom Response Following Advice On a Diet Low in Short-Chain Fermentable Carbohydrates (Fodmaps) for Functional Bowel Symptoms in Patients with Ibd. Annual Meeting of the British-Society-of-Gastroenterology (BSG), Manchester England, Jun 16-19, 2014. LONDON: BMJ PUBLISHING GROUP. doi: 10.1136/gutjnl-2014-307263.352

Symptom Response Following Advice On a Diet Low in Short-Chain Fermentable Carbohydrates (Fodmaps) for Functional Bowel Symptoms in Patients with Ibd

Availability

Dr Heidi Staudacher is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Virtually delivered dietary and lifestyle behaviour change support for people living with irritable bowel syndrome in Australia

    Associate Advisor

    Other advisors: Dr Jaimon Kelly

Enquiries

For media enquiries about Dr Heidi Staudacher's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au